ESC 365 - Prevalence of pulmonary hypertension in reduced left ventricular systolic function and its influence on outcomes

ESC Professional Premium Access

Prevalence of pulmonary hypertension in reduced left ventricular systolic function and its influence on outcomes

Session: Biomarkers - old and new - and their implication in heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor S. Ratwatte (Sydney, AU)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Seshika Ratwatte

Royal Prince Alfred Hospital, Sydney (Australia)

0 follower

3 more presentations in this session

Non-invasive pressure-volume loops from cardiovascular magnetic resonance predict cardiovascular mortality in heart failure with reduced ejection fraction

Speaker: Doctor P. Arvidsson (Lund, SE)

Non-invasive measurement of global myocardial work to predict all-cause death and heart failure hospitalization in non-ischemic cardiomyopathy

Speaker: Mr E. Rodenas Alesina (Barcelona, ES)

Food insecurity is associated with a higher body mass index and lower albumin levels in patients with congestive heart failure in the All of Us research program

Speaker: Ms H. Rtabi (New York, US)

Access the full session

Biomarkers - old and new - and their implication in heart failure

Speakers: Doctor S. Ratwatte, Doctor P. Arvidsson, Mr E. Rodenas Alesina, Ms H. Rtabi

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources